SCHEMBL7846181

SCHEMBL7846181

CCCC(=O)c1cnc2c(OCCO)cccc2c1Nc1ccc(O)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9268825 0.92 — —
SCHEMBL8178527 0.90 — —
SCHEMBL563564 0.90 ATP4A (0.80) —
SCHEMBL9506605 0.90 ATP4A (0.80) —
SCHEMBL8192240 0.89 — —
SCHEMBL9165498 0.89 ATP4A (0.79) —
SCHEMBL9165510 0.89 ATP4A (0.79) —
Hydrochloric Acid SCHEMBL9264291 0.89 ATP4A (0.79) —
SCHEMBL8190470 0.89 — —
SCHEMBL9266013 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143991-A2 INHIBITORS OF H+K+ -ATPASE Advanced Medicine, Inc. (US) 2001-10-17 — — EP disclosed
WO-1999063940-A2 INHIBITORS OF H+K+-ATPase ADVANCED MEDICINE, INC. (US) 1999-12-16 — — WO disclosed
Send feedback